PIP for POTS 2026: eligibility, descriptors and evidence. Finally Seen

POTS: diagnostic criteria and context

The diagnostic criteria for POTS — a heart rate rise of ≥30 bpm (≥40 bpm under 19s) within 10 minutes of standing or head-up tilt, with orthostatic symptoms but without a fall in blood pressure of more than 20/10 mmHg — are set out in guidance from PoTS UK (potsuk.org) and reflected in NICE guideline NG193 (2021), which addresses ME/CFS and references POTS as a comorbid condition. Formal tilt table testing is confirmatory but not essential: the NASA lean test (a structured lying-to-standing protocol measuring heart rate at 2-minute intervals over 10 minutes) is widely used in the community and increasingly accepted by cardiologists as a diagnostic tool.

POTS frequently co-occurs with hypermobile Ehlers-Danlos syndrome (hEDS), mast cell activation syndrome (MCAS), and ME/CFS. In the hEDS population, estimates of POTS prevalence range from 30% to 50%. Where POTS presents as part of a multi-system condition, each component attracts its own PIP descriptor points and should be evidenced separately.

Regulation 4 and POTS

Regulation 4 of the Social Security (Personal Independence Payment) Regulations 2013 requires that each activity be assessed for whether you can do it safely, to an acceptable standard, repeatedly, and in a reasonable time. POTS engages all four limbs in activities involving standing:

Safely: Presyncope or syncope on standing creates an acute safety risk across any activity that involves being upright — cooking at a hob, showering, walking, or using the toilet. Where collapse risk is documented by clinical records or your tilt table/NASA lean test, the safety criterion is engaged.
Repeatedly: Even if you can stand briefly once, POTS-related tachycardia and fatigue accumulate with each orthostatic challenge. If you can stand for 2 minutes to cook but then must sit for 20 minutes before standing again, you cannot cook repeatedly and should not be scored as capable of the activity.
In a reasonable time: Where every task requiring standing must be broken into short intervals separated by rest, the total time taken to complete the activity is well beyond what is reasonable — typically defined as more than twice the normal time.

Mobility descriptors for POTS

Mobility Activity 2 — moving around — is the most directly affected for POTS claimants. The descriptors are scored on how far you can walk reliably, safely, and repeatedly without stopping:

Cannot walk 20 metres (12 points — enhanced Mobility): Where presyncope or syncope occurs within a few steps of standing, the 20m threshold applies. This requires strong clinical evidence — tilt table or NASA lean test results documenting rapid symptom onset, cardiology letter confirming collapse risk, and a description of the worst typical days on PIP2.
Cannot walk 50 metres (10 points): Where standing tolerance is limited but not immediately collapseogenic, the 50m threshold may apply. Describe how many steps you can typically take before symptoms force you to stop or sit, and how long recovery takes before you can continue.
Cannot walk 200 metres (4 points): The lower threshold for POTS claimants with moderate orthostatic intolerance — symptoms develop within a few hundred metres of walking, particularly on inclines, in heat, or after meals (postprandial POTS exacerbation).

Mobility Activity 1 — planning and following journeys — may also score where cognitive impairment from cerebral hypoperfusion ("brain fog") prevents reliable journey planning, or where the risk of collapse in public places causes psychological distress that prevents independent travel (applying the MH v SSWP [2016] UKUT 531 principle).

Daily Living descriptors for POTS

Activity 1 — Preparing food: Standing at a hob is one of the most directly affected activities. Heat from cooking accelerates venous pooling and tachycardia; prolonged standing causes presyncope. Where you cannot stand at a hob for the time required to cook a simple meal safely, Activity 1 scores. Describe whether you sit on a stool, use a microwave only, eat cold food, or require another person to cook — all evidence limitation even if you nominally 'prepare food'. Score up to 8 points if you cannot prepare any meal without supervision or assistance.
Activity 4 — Washing and bathing: Hot water causes vasodilation and worsens POTS symptoms markedly. A conventional hot shower with prolonged standing — or a bath requiring getting in and out — creates a high collapse risk. Describe whether you use a shower chair, cold showers, sit on the bathroom floor, have collapsed during showering, or require another person present for safety. Score 2–4 points for needing aids; higher if another person is needed.
Activity 5 — Managing toilet needs: Rising from a seated or lying position to use the toilet — particularly at night — causes the orthostatic challenge that is most likely to produce presyncope in POTS. Where this creates a safety risk (collapse on the way to the toilet, inability to reach the toilet in time, or needing assistance to rise), Activity 5 scores.
Activity 3 — Managing treatments: POTS pharmacological management can be complex — fludrocortisone, midodrine, ivabradine, beta-blockers, and high-volume fluid and salt regimens. Where the complexity of the treatment regimen requires prompting or assistance to manage safely, Activity 3 may score.
Activity 10 — Making budgeting decisions: Cognitive impairment from cerebral hypoperfusion is a recognised feature of POTS — PoTS UK patient surveys report 'brain fog' as one of the most disabling symptoms. Where this prevents reliable financial decision-making without assistance, Activity 10 scores 2–6 points.

Medication context

The following medications are used in POTS management in the UK and their presence in prescription records evidences a clinically confirmed and actively treated condition:

Fludrocortisone: A mineralocorticoid that increases plasma volume — first-line pharmacological treatment for hypovolaemic POTS.
Midodrine: An alpha-1 agonist that increases peripheral vascular resistance and reduces venous pooling — used where fludrocortisone is insufficient.
Ivabradine: A selective sinus node inhibitor used off-licence in POTS to reduce tachycardia without the blood-pressure-lowering effects of beta-blockers.
Beta-blockers (propranolol, bisoprolol): Used at low doses to manage tachycardia, though not tolerated by all POTS patients due to hypotensive side effects.
High-salt diet and fluid loading: Clinical advice to consume ≥8–10g salt/day and 2–3 litres of fluid — often documented in cardiology or autonomic clinic letters.

Evidence to send with PIP2

Cardiology or autonomic neurology clinic letter confirming POTS, documenting the tilt table or NASA lean test result, current medication, and specific functional limitations.
Tilt table test report or NASA lean test record showing the documented heart rate rise on standing.
GP letter describing symptom history, functional impact across the PIP activities, and medication history.
Printed prescription record (from GP or NHS app) showing fludrocortisone, midodrine, ivabradine, or beta-blocker prescriptions.
PoTS UK clinician information sheet (available at potsuk.org) — attach to PIP2 to assist assessors unfamiliar with the condition.
Carer or family member statement describing what you cannot do unaided — cooking, showering, walking, and managing medication.

hEDS, MCAS and other comorbidities

POTS frequently co-occurs with hEDS and MCAS. Each condition attracts its own PIP descriptor points and should be listed and evidenced separately on PIP2. Do not allow all symptoms to be attributed to a single label — describe the functional impact of each condition on each affected activity. A combined hEDS/POTS claim routinely scores significantly higher than either condition alone. See our PIP for EDS and hypermobility guide for EDS-specific descriptor guidance.

2026 PIP rates

From April 2026, PIP rates are: Daily Living standard £76.70/week; Daily Living enhanced £114.60/week; Mobility standard £30.30/week; Mobility enhanced £80.00/week. The maximum award is £194.60/week. PIP is non-means-tested, non-taxable, and payable in and out of work. Claims are backdated to the date of the initial telephone call to DWP. PIP can also passport to the Disability Premium in legacy benefits and the enhanced disability element in Universal Credit.

›Does POTS qualify for PIP?

Yes. POTS is a form of dysautonomia characterised by a sustained heart rate rise of ≥30 bpm (≥40 bpm in those aged under 19) within 10 minutes of standing, accompanied by orthostatic symptoms — presyncope, palpitations, fatigue, cognitive impairment and sometimes syncope. Where these symptoms limit the 12 PIP activities on the majority of days, POTS attracts descriptor points across both Daily Living and Mobility components. PIP is awarded on functional impact, not diagnosis.

›Which PIP descriptors are most affected by POTS?

Mobility Activity 2 (moving around — collapse or presyncope on standing limits walking distance and reliability), Activity 1 (preparing food — inability to stand at a hob), Activity 4 (washing and bathing — heat and prolonged standing intolerance in a shower or bath), and Activity 5 (managing toilet needs — presyncope on rising from sitting) are the primary descriptor areas. Cognitive impairment ('brain fog') from cerebral hypoperfusion also affects Activity 10 (budgeting decisions) and Mobility Activity 1 (planning journeys).

›What medical evidence should I send for a POTS PIP claim?

In order of strength: (1) cardiology or autonomic neurology clinic letter confirming the POTS diagnosis, tilt table test result or NASA lean test result, current medication, and functional limitations; (2) GP letter describing your symptom history, medication trials and functional impact; (3) Holter monitor or lying/standing ECG showing the documented heart rate rise; (4) prescription record for fludrocortisone, midodrine, ivabradine, or beta-blockers; (5) a PoTS UK patient information sheet completed by your GP; (6) carer or family statement describing what you cannot do unaided.

›Can I score Mobility Enhanced rate with POTS?

Potentially yes. Mobility Activity 2 scores 12 points (enhanced Mobility rate) if you cannot walk 20 metres reliably, safely and repeatedly. Where POTS causes near-syncope within a few steps of standing — documented by tilt table test or clinical records — the 20m threshold may be met. If you can walk further than 20m but not 50m before symptoms force you to stop, score 10 points. Where cognitive impairment prevents independent journey planning, Mobility Activity 1 may add additional points.

›How does heat intolerance in POTS affect PIP?

Heat worsens venous pooling and tachycardia in POTS, making hot showers, baths, and cooking at a hob particularly hazardous. Activity 4 (washing and bathing) and Activity 1 (preparing food) both score where heat-related deterioration makes the activity unsafe or impossible without adaptation. Describe whether you use a shower chair, cold showers, sit on the bathroom floor, or require assistance — all of these evidence functional limitation even if you technically complete the activity.

›My POTS has not been formally confirmed by a tilt table test — can I still claim?

Yes. POTS is increasingly diagnosed clinically using the NASA lean test (lying/standing heart rate measurements over 10 minutes) or active standing test — formal tilt table testing is not a requirement for diagnosis and is often unavailable on the NHS. A cardiology or GP letter confirming the clinical diagnosis and describing your symptoms and functional limitations is sufficient for PIP. PoTS UK produces guidance for clinicians on diagnosing POTS without tilt table testing.

›POTS is a comorbidity of my hEDS — should I claim both together?

Yes, and you should evidence each separately. hEDS and POTS each contribute their own descriptor points across different activities. Claiming both together typically produces a higher award than either alone. Ensure your PIP2 and any supporting letters describe the functional impact of each condition independently. See our PIP for EDS and hypermobility guide for the EDS-specific descriptors.

PIP for POTS (postural tachycardia syndrome), eligibility, descriptors, and evidence